91 related articles for article (PubMed ID: 6085470)
1. Studies on the possibility of induction of anti-H-2 alloreactive cytotoxic antibodies by syngeneic immunization.
Opolski A; Radzikowski C
Arch Immunol Ther Exp (Warsz); 1984; 32(5):621-30. PubMed ID: 6085470
[TBL] [Abstract][Full Text] [Related]
2. Alloreactive cytotoxic anti-H-2 antibodies in sera of the syngeneically immunized C57BL/10ScSnPh, BALB/cJPh, and B10.A/SnPh mice.
Capková J; Hasek M; Kousalová M; Holán V; Boubelík M
Folia Biol (Praha); 1983; 29(2):200-8. PubMed ID: 6862049
[TBL] [Abstract][Full Text] [Related]
3. Induction of H-2-specific antibodies by injections of syngeneic Sendai virus-coated cells.
Kievits F; Rocca A; Opolski A; Limpens J; Leupers T; Kloosterman T; Boerenkamp WJ; Pla M; Ivanyi P
Eur J Immunol; 1987 Jan; 17(1):27-35. PubMed ID: 3028822
[TBL] [Abstract][Full Text] [Related]
4. Alloreactivity and tumor antigens: generation of syngeneic antilymphoma killer lymphocytes by alloimmunization of mice with normal cells.
Sensi ML; Parenza M; Parmiani G
J Natl Cancer Inst; 1983 Feb; 70(2):291-7. PubMed ID: 6571938
[TBL] [Abstract][Full Text] [Related]
5. Recognition of H-2Kb mutant target cells by Moloney virus-specific cytotoxic T lymphocytes from bm13 (H-2Db mutant) mice. I. Full recognition of Kbm11 by Kb-restricted CTL.
Stukart MJ; Boes J; Melief CJ
J Immunol; 1984 Jul; 133(1):24-7. PubMed ID: 6202782
[TBL] [Abstract][Full Text] [Related]
6. Recognition of H-2Kb mutant target cells by Moloney virus-specific cytotoxic T lymphocytes from bm13 (H-2Db-mutant) mice. II. Relationship of Kbm3 and Kbm11 in restriction specificities and allodeterminants.
Stukart MJ; Boes J; Melief CJ
J Immunol; 1984 Jul; 133(1):28-32. PubMed ID: 6202783
[TBL] [Abstract][Full Text] [Related]
7. Syngeneic and allogeneic mouse lymphoma antisera: specificity, reaction with fetal antigen and protective capacity.
Prager MD; Granatek CH; Ludden CM
Isr J Med Sci; 1976; 12(4-5):325-33. PubMed ID: 939692
[TBL] [Abstract][Full Text] [Related]
8. Tumor sponge implantation: an in vivo method for studying syngeneic, primary antitumor lymphocyte responses.
Vallera DA; Mentzer SJ; Maizel SE
Cancer Res; 1982 Feb; 42(2):397-404. PubMed ID: 7055792
[TBL] [Abstract][Full Text] [Related]
9. [Specificity of cell mediated cytotoxicity. I. Cytotoxic reactions in H-2 system after allogeneic sensitization in vivo].
Schulze HA; Brock J; Siegl E
Allerg Immunol (Leipz); 1982; 28(2):109-17. PubMed ID: 6182781
[TBL] [Abstract][Full Text] [Related]
10. Flow-microfluorometric monitoring of oligoclonal CD8+ T cell responses to an immunodominant Moloney leukemia virus-encoded epitope in vivo.
Brawand P; Biasi G; Horvath C; Cerottini JC; MacDonald HR
J Immunol; 1998 Feb; 160(4):1659-65. PubMed ID: 9469422
[TBL] [Abstract][Full Text] [Related]
11. Kinetics of responses to tumor antigens and mouse mammary tumor virus in BALB/cCrgl and BALB/cfC3H mice.
Lopez DM; Sigel MM; Charyulu VL
J Natl Cancer Inst; 1981 Jan; 66(1):191-6. PubMed ID: 6256573
[TBL] [Abstract][Full Text] [Related]
12. Role of a subdominant H-2Kd-restricted SV40 tumor antigen cytotoxic T lymphocyte epitope in tumor rejection.
Newmaster RS; Mylin LM; Fu TM; Tevethia SS
Virology; 1998 May; 244(2):427-41. PubMed ID: 9601511
[TBL] [Abstract][Full Text] [Related]
13. A syngeneic anti tumor serum recognizing a complex H-2 alloantigen.
Garrido F; Perez M; Torres MD; Garcia-Olivares E; Ivanyi P; Schirrmacher V
Immunobiology; 1979 Aug; 156(1-2):110-20. PubMed ID: 540966
[TBL] [Abstract][Full Text] [Related]
14. Specificity of anti-H-2 class I antibodies induced by syngeneic immunization with Sendai virus-treated cells is regulated by the mouse MHC and viral antigens. No evidence for MHC-restricted virus-specific antibodies.
Kievits F; van Bleek GM; Boerenkamp WJ; Pla M; Ivanyi P
J Immunogenet; 1989 Feb; 16(1):3-17. PubMed ID: 2550555
[TBL] [Abstract][Full Text] [Related]
15. Target sites for antibodies and cytotoxic T lymphocytes on H-2 molecules.
Rüsch E; Kuon W; Hämmerling GJ
Transplant Proc; 1983 Dec; 15(4):2093-6. PubMed ID: 6200977
[No Abstract] [Full Text] [Related]
16. LY-2+ effectors cytotoxic for syngeneic tumor cells: generation by allogeneic stimulation and by supernatants from mixed leukocyte cultures.
Hurrell SM; Zarling JM
J Immunol; 1983 Aug; 131(2):1017-23. PubMed ID: 6223084
[TBL] [Abstract][Full Text] [Related]
17. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
Sensi M; Orosz CG; Bach FH
J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
[TBL] [Abstract][Full Text] [Related]
18. Lack of specificity for viral and H-2 antigens by anomalous T killer cells generated in murine leukocyte cultures.
Shain B; Holt CA; Lilly F
J Immunol; 1982 Aug; 129(2):722-9. PubMed ID: 6177779
[TBL] [Abstract][Full Text] [Related]
19. [Humoral reactions in BALC/c mice with sarcomatous Moloney-induced tumor].
Yakimenko LV; Vetrova EP; Kaminskaya LP; Berdova AG; Umansky YA
Vopr Onkol; 1979; 25(9):46-50. PubMed ID: 573520
[TBL] [Abstract][Full Text] [Related]
20. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. II. Negative control by the Fv-1 locus in AKR mice of responder H-2b haplotype.
Green WR
J Immunol; 1984 May; 132(5):2665-71. PubMed ID: 6425410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
